YPrime eCOA for Clinical Trials: A Pediatric Migraine Study

Pediatric migraine studies demand reliable eCOA for pediatric clinical trials to capture unpredictable symptom onset and patient response. For a global trial spanning over 200 sites with more than 800 participants, a pharmaceutical leader faced persistent challenges when their existing eCOA platform couldn’t support real-time event documentation or offline randomization. They came to us looking for a better option for eCOA for clinical trials.

YPrime deployed its pediatric-friendly eCOA platform, tailored to address the specific needs of this complex migraine study. The solution included event-driven assessments, patient-initiated randomization, age-appropriate visual elements, daily check-ins, and visual medication guidance to maintain protocol compliance.

One of the standout features of this study was YPrime’s patient-initiated randomization, which enabled participants to trigger randomization during unexpected migraine events, even when devices were offline. This innovation ensured seamless continuity in study protocol and data collection, regardless of technological limitations.

Key Takeaways: Optimizing eCOA for Pediatric Clinical Trials

Deploy Real-Time Event Documentation — Learn how YPrime implemented an event-driven system to record migraine episodes as they occurred, triggering seven timed questionnaires for accurate data capture in real time.

Enable Patient-Initiated Randomization — Discover the approach that allowed patients to initiate randomization during unpredictable migraine events, even when devices were offline.

Implement Age-Appropriate Design — See how intuitive visuals can improve comprehension for younger participants, enhancing data quality and reducing patient burden.

Maintain Global Data Consistency — Explore how YPrime delivered reliable data capture from 200+ global sites across diverse regions and languages, achieving strong retention and compliance rates.

Get the Complete Case Study

Complete the form to learn how YPrime eCOA for pediatric clinical trials can effectively support studies with unpredictable events.